Products

Clarigo - Multiplicom

Enables NIPT for all

Clarigo™ is a CE marked non-invasive prenatal test (NIPT), specifically designed for implementation in local clinical laboratories to enable NIPT for all. This simple, robust and highly reliable test screens for the aneuploidy status of chromosome 21, 18 and 13 early in pregnancy using standard lab equipment. Clarigo is compatible with most of the contemporary massively parallel sequencing systems. The Clarigo CE mark was obtained after a large multi-center study comprising approximately 1,900 samples showed excellent accuracy.

Clarigo enables an optimal workflow for low to high throughput sample processing that further reduces the overall cost to a level that will make NIPT affordable for all pregnant women as an integral part of prenatal care.

The targeted design of Clarigo enables highly accurate trisomy calling of chromosomes 21, 18 and 13 based on only 2 M reads per sample, which is several times less than for shotgun approaches. Data analysis and interpretation is automated with the dedicated Clarigo™ Reporter software developed at Multiplicom and empowered by proprietary algorithms. The Clarigo Reporter further includes an intrinsic quality control assessment and provides information on the fetal fraction for each sample and optionally on fetal gender.

Show more

http://www.multiplicom.com/product/clarigo
Petra Kupková

Sales manager

Petra

Kupková

+420 731 426 051

Send Message

We supply and support Life-Science Technologies in the territory of Central and Eastern Europe.

Czech Republic

Slovakia

Hungary

Poland

Croatia

Slovenia

Serbia

Romania

Bulgaria

Latvia

Lithuania

Estonia

Russia

Ukraine

Belarus

Turkey